Best in Biotech 28 Nov 2024Six antisense oligonucleotide companies shaping the future of genetic medicine Learn more about six antisense oligonucleotide companies shaping the future of genetic medicine, just as the market is expected to grow. November 28, 2024 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 26 Nov 2024Seven miRNA-focused companies pioneering new therapies in 2024 Delve into the field of miRNA with seven companies with miRNA-focused candidates in the pipeline in 2024, from oncology to neurodegeneration. November 26, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 21 Nov 2024Eight areas where gene therapy shines Delve into the numerous applications of gene therapy, from cancer to hematological disorders and respiratory diseases. November 21, 2024 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 19 Nov 2024Six bispecific antibody companies you should know about Discover six bispecific antibody companies developing a two-in-one approach to delivering targeted therapeutics to patients. November 19, 2024 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 14 Nov 20248 biotech companies advancing new treatments for breast cancer in 2024 Delve into the diverse landscape of breast cancer treatment with nine biotech companies currently developing new treatments. November 14, 2024 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 12 Nov 2024Six exosome therapy companies driving development in the field Discover six exosome therapy companies developing these tiny extracellular vesicles to treat an array of diseases. November 12, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 7 Nov 2024Cystic fibrosis: Five biotechs breathing life into the therapeutic space In this article, we take a look at five biotechs developing potentially transformative medicines to treat this genetic disease. November 7, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 31 Oct 2024Five T cell engager companies you should know about Discover five T cell engager companies that have emerged in recent times, as this class of therapeutics is set to take off. October 31, 2024 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 29 Oct 2024GPCR therapies: Eight promising biotechs hacking the cell signaling pathway In this article, we take a look at eight biotechs that have acquired funding in recent years to fortify their GPCR-focused pipelines. October 29, 2024 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 24 Oct 2024Six biotech companies advancing multiple sclerosis therapies Take a look at six multiple sclerosis companies trying to make a difference to patients by advancing new treatments for the CNS disease. October 24, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 22 Oct 2024Eight nanotechnology companies to watch out for Here are eight nanotechnology companies that are widening the scope in medicine, that you should know about. October 22, 2024 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 17 Oct 2024Top six European biotech entrepreneurs to know in 2024 (according to VCs) We reached out to VCs to nominate prominent European entrepreneurs in the biotech industry who are committed to bringing potentially life-changing treatments to market. October 17, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email